Fol. Biol. 2015, 61, 219-226
https://doi.org/10.14712/fb2015061060219
Hepatoerythropoietic Porphyria Caused by a Novel Homoallelic Mutation in Uroporphyrinogen Decarboxylase Gene in Egyptian Patients
References
1. Anderson, K. E., Sassa, S., Bishop, D. F., Desnick, R. J. (2001) Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: The Metabolic and Molecular Bases of Inherited Disease, eds. Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., pp. 2961-3062. McGraw-Hill, New York, NY.
2. 2004) Hepatoerythropoietic porphyria: a missense mutation in the UROD gene is associated with mild disease and an unusual porphyrin excretion pattern. Br. J. Dermatol. 151, 920-923.
< , D. K. B., Sharpe, P. C., Chambers, C. R., Whatley, S. D., Roberts, A. G., Elder, G. H. (https://doi.org/10.1111/j.1365-2133.2004.06101.x>
3. 2000) Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 95, 1565-1571.
< , Z. J., Phillips, J. D., Ajioka, R. S., Franklin, M. R., Griffen, L. M., Guinee, D. J., Edwards, C. Q., Kushner, J. P. (https://doi.org/10.1182/blood.V95.5.1565.005k42_1565_1571>
4. 2010) Hepatoerythropoietic porphyria misdiagnosed as child abuse: cutaneous, arthritic, and hematologic manifestations in sibling with a novel UROD mutation. Arch. Dermatol. 146, 529-533.
, J. L., Cohen, J., Balwani, M., Kahn, P., Lazarus, H. M., Desnick, R. J., Schaffer, J. V. (
5. 2002) Precipitating/ aggravating factors of porphyria cutanea tarda in Spanish patients. Cell. Mol. Biol. 48, 845-852.
, J., Fontanellas, A., Morán-Jiménez, M. J., Navarro- Ordoñez, S., García-Bravo, M., Méndez, M., Muñoz- Rivero, M. C., Enríquez de Salamanca, R. (
6. 1978) Familial and sporadic porphyria cutanea tarda, two different diseases. Hum. Genet. 44, 145-51.
< , H., Aitken, G., Nordmann, Y. (https://doi.org/10.1007/BF00295407>
7. 1984) Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria. Am. J. Hum. Genet. 36, 613-622.
, H., Beaumont, C., Deybach, J. C., Nordmann, Y., Sfar, Z., Kastally, R. (
8. 1986) Uroporphyrinogen decarboxylase structural mutant (Gly281—Glu) in a case of porphyria. Science 234, 732-734.
< , H., Grandchamp, B., Beaumont, C., Picat, C., Nordmann, Y. (https://doi.org/10.1126/science.3775362>
9. 1992) Characterisation of a new mutation (R292G) and a deletion at the human uroporphyrinogen decarboxylase locus in two patients with hepatoerythropoietic porphyria. Hum. Genet. 89, 548-552.
, H., Bourgeois, F., de Rooij, F., Siersema, P. D., Wilson, J. H. P., Grandchamp, B., Nordmann, Y. (
10. 1986) Assignment of human uroporphyrinogen decarboxylase (URO-D) to the p34 band of chromosome 1. Hum. Genet. 73, 277-279.
< , A., Mattei, M. G., Raich, N., Beaupain, D., Romeo, P. H., Mattei, J. F., Goossens, M. (https://doi.org/10.1007/BF00401245>
11. 1978). Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda. N. Engl. J. Med. 299, 274-278.
< , G. H., Lee, G. B., Tovey, J. A. (https://doi.org/10.1056/NEJM197808102990603>
12. 1981) Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda? Lancet 317, 916-919.
< , G. H., Smith, S. G., Herrero, C., Mascaro, J. M, Lecha, M., Muniesa, A. M., Czarnecki, D. B., Brenan, J., Poulos, V., de Salamanca, R. E. (https://doi.org/10.1016/S0140-6736(81)91615-9>
13. 1998) Porphyria cutanea tarda. Semin. Liver Dis. 18, 67-75.
< , G. H. (https://doi.org/10.1055/s-2007-1007142>
14. 1992) Hepatitis virus and porphyr- ia cutanea tarda: evidence of a strong association. Hepatology 16, 1322-1326.
< , S., Piperno, A., Cappellini, M., Sampietro, M., Fracanzani, A., Romano, R., Caldarelli, R., Marcelli, R., Vecchi, L., Fiorelli, G., (https://doi.org/10.1002/hep.1840160603>
15. 2003) Prevalence of hepatitis C virus infection in porphyria cutanea tarda. J. Hepatol. 39, 635-638.
< , S., Fracanzani, A. L. (https://doi.org/10.1016/S0168-8278(03)00399-4>
16. 2002) Description of a new mutation in hepatoerythropoietic porphyria and prenatal exclusion of a homozygous fetus. Arch. Dermatol. 138, 957-960.
< , C., Ozalla, D., Herrero, C., Lecha, M., Mendez, M., De Verneuil, H., Mascaro, J. M. (https://doi.org/10.1001/archderm.138.7.957>
17. 2009) The very first description of a patient with hepatoerythropoietic porphyria in Argentina. Biochemical and molecular studies. Cell. Mol. Biol. (Noisy-le-Grand) 55, 61-65.
, B. X., Parea, V. E., Melito, V. A., Teijo, M. J., Battle A. M., Rossetti, M. V. (
18. 2008) The biochemistry of heme biosynthesis. Arch. Biochem. Biophys. 474, 238-251.
< , I. U., Jahn, M., Jahn, D. (https://doi.org/10.1016/j.abb.2008.02.015>
19. 2006) The heme-Bach1 pathway in the regulation of oxidative stress response and erythroid differentiation. Antioxid. Redox Signal. 8, 107-118.
< , K., Sun, J. (https://doi.org/10.1089/ars.2006.8.107>
20. 1976) Macrocyclic intermediates in the biosynthesis of porphyrins. Philos. Trans. R. Soc. Lond. B Biol. Sci. 273, 191-206.
, A. H., Sancovich, H. A., Ferramola, A. M., Evans, N., Games, D. E., Matlin, S. A., Elder, G. H., Smith, S. G. (
21. 2015) Notch activity modulates the responsiveness of neural progenitors to sonic hedgehog signaling. Dev. Cell 33, 373-387.
< , J. H., Yang, L., Dessaud, E., Chuang, K., Moore, D. M., Rohatgi, R., Briscoe, J., Novit, B. G. (https://doi.org/10.1016/j.devcel.2015.03.005>
22. 1983) Separation of porphyrin isomers by high-performance liquid chromatography. Biochem. J. 211, 435-438.
< , C. K., Rideout, J. M., Wright, D. J. (https://doi.org/10.1042/bj2110435>
23. Liu, L., Philipps, J., Bonkovski, H., Porphyrias Consortium of the Rare Diseases Clinical Research Network (2013) Hepatoerythropoietic porphyria. In: GeneReviews, eds. Pagon, R. A., Adam, M. P., Ardinger, H. H., pp. 1993-2015. University of Washington, Seattle, WA.
24. 2013) Hemebased globin-coupled oxygen sensors: Linking oxygen binding to functional regulation of diguanylate cyclase, histidine kinase, and methyl-accepting chemotaxis. J. Biol. Chem. 288, 27702-27711.
< , M., Kitanishi, K., Shimizu, T. (https://doi.org/10.1074/jbc.R113.473249>
25. 1994) Molecular defects of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria. J. Invest. Dermatol. 102, 681-685.
< , K., Fujita, H., Ishida, N., Akagi, R., Kurihara, T., Galbraith, R. A., Kappas, A., Zabriskie, J. B., Toback, A. C., Harber, L. C., et al. (https://doi.org/10.1111/1523-1747.ep12374134>
26. 2005) The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population. J. Am. Acad. Dermatol. 52, 417-424.
< , M., Rossetti, M. V., Batlle, A., Parera, V. (https://doi.org/10.1016/j.jaad.2004.09.014>
27. 2006) Heme: a versatile signaling molecule controlling the activities of diverse regulators ranging from transcription factors to MAP kinases. Cell Res. 16, 681-692.
< , S., Zhang, L. (https://doi.org/10.1038/sj.cr.7310086>
28. 1996) Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria. Am. J. Hum. Genet. 58, 712-721.
, M. J., Ged, C., Romana, M., Enríquez de Salamanca, R., Taiëb, A., Topi, G., D’Alessandro, L., de Verneuil, H., (
29. 1998) Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection. Hepatology 27, 584-589.
< , M. J., Fontanellas, A., Brudieux, E., Hombrados, I., de Ledinghen, V., Couzigou, P., de Verneuil, H., De Salamanca, R. (https://doi.org/10.1002/hep.510270237>
30. 2010) Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients. Medicine (Baltimore) 89, 69-74.
< , C., Guilabert, A., Moreno, N., To-Figueras, J., Badenas, C., Darwich, E., Herrero, C. (https://doi.org/10.1097/MD.0b013e3181d50928>
31. 2002) Human hereditary hepatic porphyrias. Clin. Chim. Acta 325, 17-37.
< , Y., Puy, H. (https://doi.org/10.1016/S0009-8981(02)00276-0>
32. 2001) Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1. EMBO J. 20, 2835-2843.
< , K., Sun, J., Taketani, S., Nakajima, O., Nishitani, C., Sassa, S., Hayashi, N., Yamamoto, M., Shibahara, S., Fujita, H., Igarashi, K. (https://doi.org/10.1093/emboj/20.11.2835>
33. 1989) Haem as a multifunctional regulator. Trends Biochem. Sci. 14, 492-496.
< , G., Venkateswar, V., Rangarajan, P. N. (https://doi.org/10.1016/0968-0004(89)90182-5>
34. 1969) A case of biochemically unclassifiable hepatic porphyria. Br. J. Dermatol. 81, 270-275.
< , J., Castells, A., Indacochea, A., Rodes, J. (https://doi.org/10.1111/j.1365-2133.1969.tb13979.x>
35. 2003) Structural basis for tetrapyrrole coordination by uroporphyrinogen decarboxylase. EMBO J. 22, 6225-6233.
< , J. D., Whitby, F. G., Kushner, J. P., Hill, C. P. (https://doi.org/10.1093/emboj/cdg606>
36. 2007) Two novel uroporphyrinogen decarboxylase (URO-D) mutations causing hepatoerythropoietic porphyria (HEP). Transl. Res. 149, 85-91.
< , J. D., Whitby, F. G., Stadtmueller, B. M., Edwards, C. Q., Hill, C. P. Kushner, J. P. (https://doi.org/10.1016/j.trsl.2006.08.006>
37. 2010) Porphyrias. Lancet 375, 924-937.
< , H., Gouya, L., Deybach, J. C. (https://doi.org/10.1016/S0140-6736(09)61925-5>
38. 2007) Identification of heme as the ligand for the orphan nuclear receptors REVERBα and REV-ERBβ. Nat. Struct. Mol. Biol. 14, 1207-1213.
< , S., Stayrook, K. R., Huang, P., Rogers, P. M., Nosie, A. K., McClure, D. B., Burris, L. L., Khorasanizedeh, S., Burris, T. P., Rastinejad, F. (https://doi.org/10.1038/nsmb1344>
39. 2008) Childhood-onset mild cutaneous porphyria with compound heterozygotic mutations in the uroporphyrinogen decarboxylase gene. Clin. Exp. Dermatol. 33, 602-605.
< , E., Lecha, M., Badenas, C., Koszo, F., Vass, V., Herrero, C., Varga, V., Emri, G., Balogh, A., Horkay, I. (https://doi.org/10.1111/j.1365-2230.2008.02734.x>
40. 1995) A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients. J. Invest. Dermatol. 104, 500-502.
< , A. G., Elder, G. H., De Salamanca, R. E., Herrero, C., Lecha, M., Mascaro, J. M. (https://doi.org/10.1111/1523-1747.ep12605953>
41. 1986) Hepatitis B virus infection in porphyria cutanea tarda. Liver 6, 153-157.
< , E., Gibertini, P., Cassanelli, M., Pietrangelo, A., Jensen, J., Ventura, E. (https://doi.org/10.1111/j.1600-0676.1986.tb00282.x>
42. 1987) Structure of the gene for human uroporphyrinogen decarboxylase. Nucleic Acids Res. 15, 7343-7356.
< , M., Dubart, A., Beaupain, D., Chabret, C., Goossens, M., Romeo, P. H., (https://doi.org/10.1093/nar/15.18.7343>
43. 1986) Molecular cloning and nucleotide sequence of a complete human uroporphyrinogen decarboxylase cDNA. J. Biol. Chem. 261, 9825-9831.
< , P. H., Raich, N., Dubart, A., Beaupain, D., Pryor, M., Kushner, J. P., Cohen-Solal, M., Goossens, M. (https://doi.org/10.1016/S0021-9258(18)67589-1>
44. 2008) Genetic and biochemical studies in Argentinean patients with variegate porphyria. BMC Med. Genet. 9, 54.
< , M. V., Granata, B. X., Giudice, J., Parera, V. E., Batlle, A. (https://doi.org/10.1186/1471-2350-9-54>
45. 2015) Gaseous O2, NO, and CO in signal transduction: structure and function relationships of heme-based gas sensors and heme-redox sensors. Chem. Rev. 115, 6491-6533.
< , T., Huang, D., Yan, F., Stranava, M., Bartosova, M., Fojtíková, V., Martínková, M. (https://doi.org/10.1021/acs.chemrev.5b00018>
46. 2005) Density-functional study of mechanisms for the cofactor-free decarboxylation performed by uroporphyrinogen III decarboxylase. J. Phys. Chem. B. 109, 18195-18200.
< , P. J., Ramos, M. J. (https://doi.org/10.1021/jp051792s>
47. 2011) Hepatoerythropoietic porphyria due to a novel mutation in the uroporphyrinogen decarboxylase gene. Br. J. Dermatol. 165, 499-505.
, J., Phillips, J., Gonzales-López, Badenas, C., Madrigal, I., Gonzáles-Romarís, E. M., Ramos, C., Aguirre, J. M., Herrero C. (
48. 1998) A zebrafish model for hepatoerythropoietic porphyria. Nat. Genet. 20, 239-243.
< , H., Long, Q., Marty, S. D., Sassa, S., Lin, S. (https://doi.org/10.1038/3041>
49. 1998). Crystal structure of human uroporphyrinogen decarboxylase. EMBO J. 17, 2463-2471.
< , F. G., Phillips, J. D., Kushner, J. P., Hill, C. P. (https://doi.org/10.1093/emboj/17.9.2463>
50. 1995) Congenital erythropoietic porphyria: identification and expression of 10 mutations in the uroporphyrinogen III synthase gene. J. Clin. Invest. 95, 905-912.
< , W., Warner, C. A., Desnick, R. J. (https://doi.org/10.1172/JCI117742>